By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies said on Friday it intends to redeem all of the outstanding 1.5 percent convertible senior notes due 2024.

The company intends to redeem the all of the notes on Feb. 15, and said that as of Dec. 31, 2011, $450 million in aggregate principal amount of the notes were outstanding. The notes are convertible prior to Feb. 14, 5 p.m. EST at a rate of 19.603 shares of common stock for each $1,000 principal amount of the notes surrendered.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.